In previous genome‐wide association study, researchers identified MTHFR and TCN2, two Hcy metabolism regulatory genes, as novel susceptibility genes for MMD, which were significantly associated with high‐serum Hcy levels in MMD.33 This evidence concerns the gene TCN2 and multiminicore myopathy.